Benitec Biopharma Inc. reports $4.4 million Q3 loss
The company generated $0.54 million in quarterly revenue
By USInMinutes
Published - May 15, 2023, 02:31 PM ET
Last Updated - Jul 18, 2023, 03:26 PM EDT
Benitec Biopharma Inc. [BNTC] has reported fiscal Q3 loss of $4.40 million.
On a per-share basis, the DE based company said its diluted earnings are $0.16.
The Pharmaceutical Preparations firm posted revenue of $0.54 million in this period.
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Contact Us
Our Offices
10kInfo, Inc.
13555 SE 36th St
Bellevue, WA 9800610kInfo Data Solutions, Pvt Ltd.
Claywork Create
11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
Bengaluru, Karnataka 560076
4.2 12182024
Read More from Investing